Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology , today announced that Pearl Huang, Ph.D., President and Chief Executive Officer, will present a company overview at the Piper Sandler 32nd Annual Virtual Healthcare Conference. The presentation will be available fo
CAMBRIDGE, Mass., Nov. 23, 2020 /PRNewswire/ --Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology, today announced that Pearl Huang, Ph.D., President and Chief Executive Officer, will present a company overview at the Piper Sandler 32nd Annual Virtual Healthcare Conference. The presentation will be available for registered attendees from November 23, 2020 to December 3, 2020 through the Piper Sandler conference site. About Cygnal Therapeutics View original content:http://www.prnewswire.com/news-releases/cygnal-therapeutics-to-present-at-the-piper-sandler-32nd-annual-virtual-healthcare-conference-301178525.html SOURCE Cygnal Therapeutics |